Michael Wiese

Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)

Anne Pick, Henrik Müller, Ralf Mayer et al. · Bioorganic & Medicinal Chemistry · 2010 · 188 citations · Full text

Biochemistry, Medicine, Phytochemical +5

Pharmacophore Model of Drugs Involved in P-Glycoprotein Multidrug Resistance:  Explanation of Structural Variety (Hypothesis)

Ilza Pajeva, Michael Wiese · Journal of Medicinal Chemistry · 2002 · 151 citations · Full text

Drug Target, Glycobiology, Chemical Biology +17

Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein

Kapil Juvale, Veronika F.S. Pape, Michael Wiese · Bioorganic & Medicinal Chemistry · 2011 · 116 citations · Full text

Breast Oncology, Medicine, Drug Discovery +5

Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance

Veronika F.S. Pape, Szilárd Tóth, András Füredi et al. · European Journal of Medicinal Chemistry · 2016 · 105 citations

Medicinal Chemistry, Biochemistry, Medicine +11

Synthesis and Structure−Activity Relationships of Suramin-Derived P2Y₁₁Receptor Antagonists with Nanomolar Potency

Heiko Ullmann, Sabine Meis, Darunee Hongwiset et al. · Journal of Medicinal Chemistry · 2005 · 92 citations · Full text